Sarah Anand, MD
Hematology · Ann Arbor, MINPI 1023218120
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,993 of the $13,840 with a category attached, or 72.2%. Every reported general payment came from a single manufacturer, CSL Behring. Reporting peaked in 2019 at $10,343 and has fallen 92.9% since, to $733 in 2024.
Across 24 payments — averaging $576.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$14K
Across 297 payments — averaging $8286.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$2.4M
- Incyte Corporation$67K
What the payments were for
- Speaking & faculty fees$3,49825%
- Travel & lodging$9,99372%
- Food & beverage$3493%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 24 | $13,840 |
How this compares
$13,840 in reported general payments places this provider in the 75th percentile of 50 hematology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JakafiRuxolitinib Phosphate | 49 | $613,605 |
| Posaconazole | 35 | $33,726 |
| RestasisCyclosporine | 14 | $10,263 |
| Ursodiol | 21 | $1,940 |
| Acyclovir | 21 | $652 |
| Budesonide DrBudesonide | 12 | $372 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 42 | $310 |
| Omeprazole | 14 | $258 |
| Prednisone | 13 | $158 |
Paid to pharmacies, not to this prescriber.
Other hematology in Ann Arbor
- Matthew PiankoAnn Arbor$51K
- Sami MalekAnn Arbor$49K
- Yasmin KarimiAnn Arbor$47K
- Kristen PettitAnn Arbor$45K
- Samuel SilverAnn Arbor$23K
- Jordan SchaeferAnn Arbor$14K
- John MagenauAnn Arbor$13K
- Charles FoucarAnn Arbor$11K
- Patrick BurkeAnn Arbor$6K
- Dale BixbyAnn Arbor$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.